Detection of specific mutations in genes encoding for PD-L1 and PD-L2 may help predict which patients with lymphoma will benefit from immune checkpoint inhibitor therapy.
from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2SaoIB1
from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2SaoIB1